You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康緣藥業(600557.SH)擬推880萬股的2022年度限制性股票激勵計劃
格隆匯 04-11 18:58

格隆匯4月11日丨康緣藥業(600557.SH)發佈2022年度限制性股票激勵計劃(草案),擬向激勵對象授予限制性股票數量880萬股,約佔草案公吿日公司股本總額的1.53%。其中首次授予800萬股,約佔草案公吿日公司股本總額的1.39%,約佔此次授予權益總額的90.91%;預留80萬股,約佔草案公吿日公司股本總額的0.14%,約佔此次授予權益總額的9.09%。

該激勵計劃限制性股票的授予價格為每股7.92元(含預留)。該激勵計劃首次擬授予的限制性股票激勵對象總人數為不超過163人,包括:(1)公司董事、負責銷售業務的高級管理人員(2)公司研發系統及銷售系統核心人員

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account